Csenge Advisory Group’s CyrusOne Inc Common Stock CONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,222
Closed -$227K 721
2021
Q4
$227K Buy
+3,222
New +$273K 0.02% 501
2021
Q3
Sell
-3,222
Closed -$227K 625
2021
Q2
$227K Hold
3,222
0.02% 504
2021
Q1
$224K Sell
3,222
-96
-3% -$6.66K 0.02% 455
2020
Q4
$243K Buy
3,318
+30
+0.9% +$2.18K 0.03% 370
2020
Q3
$254K Buy
+3,288
New +$258K 0.03% 326
2020
Q1
Sell
-3,391
Closed -$222K 354
2019
Q4
$222K Sell
3,391
-105
-3% -$7.21K 0.06% 263
2019
Q3
$277K Sell
3,496
-505
-13% -$33.7K 0.08% 217
2019
Q2
$231K Sell
4,001
-80
-2% -$4.69K 0.08% 169
2019
Q1
$214K Hold
4,081
0.07% 184
2018
Q4
$215K Buy
4,081
+999
+32% +$57.1K 0.08% 174
2018
Q3
$167K Buy
+3,082
New +$199K 0.06% 184

Other funds holding CONE

Csenge Advisory Group's CONE Position: Q1 2022 in Review

Csenge Advisory Group sold out of CyrusOne Inc Common Stock (CONE) in Q1 2022, closing a stake of 3,222 shares — an estimated $227K sold.

Csenge Advisory Group first reported a position in CONE in Q3 2018 and held it in 11 quarters. The position peaked at $277K in Q3 2019. 3 funds tracked by Wall St. Rank hold CONE as of Q1 2022.

  • Csenge Advisory Group reported no remaining CyrusOne Inc Common Stock position as of Q1 2022 after selling out during the quarter.
  • Csenge Advisory Group sold 3,222 CyrusOne Inc Common Stock shares in Q1 2022, an estimated $227K.
  • Csenge Advisory Group first reported a position in CyrusOne Inc Common Stock in Q3 2018 and held it in 11 quarters.
  • Csenge Advisory Group's CyrusOne Inc Common Stock position peaked at $277K in Q3 2019.
  • 3 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q1 2022.

Based on Csenge Advisory Group's 13F filing for Q1 2022, filed 9 May 2022.